Asia-Pacific Orthobiologics Market - Industry Trends and Forecast to 2026

  • Medical Devices
  • Upcoming Report
  • Oct 2019
  • Asia-Pacific
  • 150 Pages
  • No of Tables: 30
  • No of Figures: 50

Asia-Pacific Orthobiologics Market By Products (Demineralized Bone Matrix (DBM), Allograft, Bone Morphogenetic Protein (BMP), Viscosupplementation, Synthetic Bone Substitutes, Stem Cell Therapy, Bone Marrow Aspirate Protein, Plasma-Rich Protein, Other Products), Application (Spinal Fusion, Trauma Repair, Reconstructive Surgery, Tendon And Ligament, Osteoarthritis and Degenerative Arthritis, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial and Dental Applications, Others), By Type ( Knee, Ankle, Hip, Wrist & Shoulder, Spine, Others), By End-User (Hospitals, Orthopedic Clinics & Ambulatory Care Centers, Research & Academic Institutes, Dental Clinics and Facilities), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest Of Asia-Pacific) - Industry Trends and Forecast to 2026

Market Analysis: Asia-Pacific Orthobiologics Market

Asia-Pacific orthobiologics market is registering a substantial CAGR of 7.39% in the forecast period of 2019-2026. This rise in the market value can be attributed to the surging orthopedic related diseases due to lifestyle choices and increased consciousness among individuals due to orthobiological advantages.

Market Definition: Asia-Pacific Orthobiologics Market

Orthobiologics are drugs that are used by orthopedic surgeons to assist cure wounds faster. They are used to enhance regeneration of damaged joints and tissues, tendons and ligaments that have been wounded. These products are produced of normally occurring drugs in your flesh. Using orthobiologics drugs in greater levels helps speed up the healing process. Some main advantages connected with conservative orthobiologics therapies include minimizing the effect of degenerative disease, completing all processes as an outpatient in the workplace and regeneration is faster than surgery.

Market Drivers

  • Growing old population, is driving the growth of the market
  • Surging orthopedic related diseases due to lifestyle choices, is propelling the growth of the market
  • Technological advancement in the orthobiologics,  is boosting the growth of the market
  • Increased consciousness among individuals due to orthobiological advantages, is contributing to the growth of the market

Market Restraints

  • Strict government guidelines, are restricting the growth of the market.
  • Post-surgery difficulties, is hindering the growth of the market
  • High charge of orthopedic implants, is hampering the growth of the market

Segmentation: Asia-Pacific Orthobiologics Market

By Products

  • Demineralized bone matrix (DBM)
  • Allograft
  • Bone morphogenetic protein (BMP)
  • Viscosupplementation
  • Synthetic bone substitutes
  • Stem cell therapy
  • Bone Marrow Aspirate Protein
  • Plasma-Rich Protein
  • Other Products

By Application

  • Spinal fusion
  • Trauma repair
  • Reconstructive surgery
  • Tendon and ligament
  • Osteoarthritis and Degenerative Arthritis
  • Soft-Tissue Injuries
  • Fracture Recovery
  • Maxillofacial and Dental Applications
  • Others

By Type

  • Knee
  • Ankle
  • Hip
  • Wrist & Shoulder
  • Spine

  • Others

By End-User

  • Hospitals
  • Orthopedic clinics & Ambulatory Care Centers
  • Research & Academic Institutes
  • Dental Clinics and Facilities

By Country

  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of Asia-Pacific

 Key Developments in the Market:

  • In January 2019, Bioventus, a worldwide player in orthobiological alternatives, is introducing OSTEOMATRIX+, its next generation of biphasic bone graft for bone remodeling in a multitude of orthopedic and spinal applications. OSTEOMATRIX+ is a moldable bone graft replacement composed of bovine collagen and biphasic, hydroxyapatite / ß-tricalcium carbon granules for the production of safe, porous and maintained osteoconductivity throughout bone remodeling phase.
  • In January 2016, Bioventus, a specialist in orthobiologic alternatives, has announced its introduction into the child service industry in Taiwan with the release of DUROLANE, single-injection joint-fluid arthritis (OA) therapy centered on a normal, secure and demonstrated NASHA technique that produces stable hyaluronic acid (HA). Hyaluronic acid is a natural molecule that lubricates and cushions in a standard pair.

Competitive Analysis:

Asia-Pacific orthobiologics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of orthobiologics market for Asia-Pacific.

Key Market Competitors:

Few of the major market competitors currently working in the Asia-Pacific orthobiologics market are  Baxter, CONMED Corporation, DePuy Synthes, Exactech, Inc., Integra LifeSciences Corporation, Medtronic, NuVasive, Inc., RTI Surgical Holdings, Inc., Sanofi, Smith & Nephew, Stryker, Zimmer Biomet, SINTX Technologies, Inc., AlloSource, aap Implantate AG and others.

Research Methodology: Asia-Pacific Orthobiologics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others

Reasons to Purchase this Report

  • Current and future of Asia-Pacific orthobiologics market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE